Mirum Pharmaceuticals, Inc. (MIRM) stock
MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$91.95+0.37 (+0.40%)
Close on Nov 17, 2026Market cap $5.97BP/E –Yield –
Mirum Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Mirum Pharmaceuticals's cash was $438.29M at Jun 30, 2026. For fiscal 2025 it was $383.33M, up 36.7% from the year before. The highest annual figure on record is $383.33M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $383.33M | +36.7% |
| FY2024 | Dec 31, 2024 | $280.32M | -2.1% |
| FY2023 | Dec 31, 2023 | $286.33M | +88.7% |
| FY2022 | Dec 31, 2022 | $151.72M | -3.1% |
| FY2021 | Dec 31, 2021 | $156.54M | -32.5% |
| FY2020 | Dec 31, 2020 | $231.82M | +98.7% |
| FY2019 | Dec 31, 2019 | $116.66M | +124.5% |
| FY2018 | Dec 31, 2018 | $51.96M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $438.29M | +43.9% |
| Q1 FY2026 | Mar 31, 2026 | $386.26M | +39.1% |
| Q4 FY2025 | Dec 31, 2025 | $383.33M | +36.7% |
| Q3 FY2025 | Sep 30, 2025 | $375.55M | +32.0% |
| Q2 FY2025 | Jun 30, 2025 | $304.55M | +9.4% |
| Q1 FY2025 | Mar 31, 2025 | $277.67M | -8.3% |
| Q4 FY2024 | Dec 31, 2024 | $280.32M | -2.1% |
| Q3 FY2024 | Sep 30, 2024 | $284.45M | -7.1% |
| Q2 FY2024 | Jun 30, 2024 | $278.37M | -15.6% |
| Q1 FY2024 | Mar 31, 2024 | $302.84M | +99.6% |
| Q4 FY2023 | Dec 31, 2023 | $286.33M | +54.5% |
| Q3 FY2023 | Sep 30, 2023 | $306.03M | +144.9% |
| Q2 FY2023 | Jun 30, 2023 | $329.95M | +135.8% |
| Q4 FY2022 | Dec 31, 2022 | $151.72M | -3.1% |
| Q3 FY2022 | Sep 30, 2022 | $185.35M | -2.5% |
| Q2 FY2022 | Jun 30, 2022 | $124.95M | -44.2% |
| Q1 FY2022 | Mar 31, 2022 | $139.91M | -34.4% |
| Q4 FY2021 | Dec 31, 2021 | $156.54M | -32.5% |
| Q3 FY2021 | Sep 30, 2021 | $190.03M | +42.1% |
| Q2 FY2021 | Jun 30, 2021 | $223.85M | +49.9% |
| Q1 FY2021 | Mar 31, 2021 | $213.11M | +33.6% |
| Q4 FY2020 | Dec 31, 2020 | $231.82M | +98.7% |
| Q3 FY2020 | Sep 30, 2020 | $133.75M | +5.9% |
| Q2 FY2020 | Jun 30, 2020 | $149.34M | +77.4% |
| Q1 FY2020 | Mar 31, 2020 | $159.53M | +207.0% |
| Q4 FY2019 | Dec 31, 2019 | $116.66M | – |
| Q3 FY2019 | Sep 30, 2019 | $126.26M | – |
| Q2 FY2019 | Jun 30, 2019 | $84.19M | – |
| Q4 FY2018 | Dec 31, 2018 | $51.96M | – |
See a number that looks wrong?